Table 1:

Major clinical characteristics of 18 patients with morphea included in the study

Age (median, range), yrs	(48.8, 31–75)
Gender (female/male)	14/4
Disease duration (mean ± SD) ( yrs)	3.8 ± 1.1
Morphea subtype:
Linear	0 (0%)
plaque	15 (82.3%)
generalized plaque	3 (16.7%)
Treatment:
Topical	14 (77.8%)
systemic	2 (11.1%)
none	2 (11.1%)